Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bayssas

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Pharmaceutics|August 15, 2002
Oxaliplatin loaded PLAGA microspheres: design of specific release profilesF Lagarce, O Cruaud, C Deuschel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Clinical pharmacokinetics of oxaliplatin: a critical reviewM A Graham, G F Lockwood, D Greenslade, et al.
Breast Cancer Research and Treatment|January 1, 1995
Current status of Taxotere (docetaxel) as a new treatment in breast cancerP Fumoleau, B Chevallier, P Kerbrat, et al.
Stem Cells (Dayton, Ohio)|May 1, 1994
In vivo stimulation of neutrophil function by lenograstim (glycosylated rHuG-CSF) in oncohematologic patients: results of a phase I trialC Fossat, A M Stoppa, D Sainty, et al.
La Nouvelle Presse Medicale|October 28, 1978
[Immune functions in cancers of the upper respiratory and digestive tracts]J Y Follézou, M Bayssas, M A Provost, et al.
Anti-Cancer Drugs|January 12, 2000
Phase I trial of intoplicine (RP 60475) administered as a 72 h infusion every 3 weeks in patients with solid tumorsR A Newman, J Kim, B M Newman, et al.
British Journal of Haematology|January 1, 1993
In vivo administration of recombinant granulocyte colony stimulating factor corrects acquired neutrophil function deficiency association with chronic graft-versus-host diseaseA M Stoppa, C Fossat, D Sainty, et al.
Anti-Cancer Drugs|February 1, 1996
Phase I and pharmacology study of intoplicine (RP 60475; NSC 645008), novel topoisomerase I and II inhibitor, in cancer patientsD Abigerges, J P Armand, G G Chabot, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase I clinical and pharmacokinetic study of LY 195448J Cassidy, C Lewis, L Adams, et al.
Lancet (London, England)|August 11, 1979
Aclacinomycin A in acute leukaemias and lymphomasG Mathé, F Gescher, M Bayssas, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Pharmaceutics|August 15, 2002
Oxaliplatin loaded PLAGA microspheres: design of specific release profilesF Lagarce, O Cruaud, C Deuschel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Clinical pharmacokinetics of oxaliplatin: a critical reviewM A Graham, G F Lockwood, D Greenslade, et al.
Breast Cancer Research and Treatment|January 1, 1995
Current status of Taxotere (docetaxel) as a new treatment in breast cancerP Fumoleau, B Chevallier, P Kerbrat, et al.
Stem Cells (Dayton, Ohio)|May 1, 1994
In vivo stimulation of neutrophil function by lenograstim (glycosylated rHuG-CSF) in oncohematologic patients: results of a phase I trialC Fossat, A M Stoppa, D Sainty, et al.
La Nouvelle Presse Medicale|October 28, 1978
[Immune functions in cancers of the upper respiratory and digestive tracts]J Y Follézou, M Bayssas, M A Provost, et al.
Anti-Cancer Drugs|January 12, 2000
Phase I trial of intoplicine (RP 60475) administered as a 72 h infusion every 3 weeks in patients with solid tumorsR A Newman, J Kim, B M Newman, et al.
British Journal of Haematology|January 1, 1993
In vivo administration of recombinant granulocyte colony stimulating factor corrects acquired neutrophil function deficiency association with chronic graft-versus-host diseaseA M Stoppa, C Fossat, D Sainty, et al.
Anti-Cancer Drugs|February 1, 1996
Phase I and pharmacology study of intoplicine (RP 60475; NSC 645008), novel topoisomerase I and II inhibitor, in cancer patientsD Abigerges, J P Armand, G G Chabot, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase I clinical and pharmacokinetic study of LY 195448J Cassidy, C Lewis, L Adams, et al.
Lancet (London, England)|August 11, 1979
Aclacinomycin A in acute leukaemias and lymphomasG Mathé, F Gescher, M Bayssas, et al.
Pageof 3